Determinants of treatment in patients with stage IV renal cell carcinoma

Advances in systemic targeted therapies afford treatment opportunities in patients with metastatic renal cell carcinoma (RCC). Elderly patients with metastatic RCC present a subpopulation for consideration owi...

Source: BMC Urology - November 29, 2019 Category: Urology & Nephrology Authors: Christopher S. Hollenbeak, Eric W. Schaefer, Justin Doan and Jay D. Raman Tags: Research article Source Type: research